PL1727562T3 - Sposób szczepienia przeciw zakażeniu jąder wirusem BVD - Google Patents

Sposób szczepienia przeciw zakażeniu jąder wirusem BVD

Info

Publication number
PL1727562T3
PL1727562T3 PL05708706T PL05708706T PL1727562T3 PL 1727562 T3 PL1727562 T3 PL 1727562T3 PL 05708706 T PL05708706 T PL 05708706T PL 05708706 T PL05708706 T PL 05708706T PL 1727562 T3 PL1727562 T3 PL 1727562T3
Authority
PL
Poland
Prior art keywords
vaccination against
bvdv infection
against testicular
testicular bvdv
infection
Prior art date
Application number
PL05708706T
Other languages
English (en)
Inventor
Michael Aaron Ellsworth
Cassius Mcallister Tucker
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of PL1727562T3 publication Critical patent/PL1727562T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL05708706T 2004-03-17 2005-03-04 Sposób szczepienia przeciw zakażeniu jąder wirusem BVD PL1727562T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55386704P 2004-03-17 2004-03-17
PCT/IB2005/000610 WO2005089793A1 (en) 2004-03-17 2005-03-04 Method of vaccination against testicular bvdv infection
EP05708706A EP1727562B1 (en) 2004-03-17 2005-03-04 Method of vaccination against testicular bvdv infection

Publications (1)

Publication Number Publication Date
PL1727562T3 true PL1727562T3 (pl) 2008-10-31

Family

ID=34961163

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05708706T PL1727562T3 (pl) 2004-03-17 2005-03-04 Sposób szczepienia przeciw zakażeniu jąder wirusem BVD

Country Status (23)

Country Link
US (1) US20080260778A1 (pl)
EP (1) EP1727562B1 (pl)
JP (1) JP4105220B2 (pl)
KR (2) KR20060127199A (pl)
CN (1) CN1929859A (pl)
AR (1) AR048671A1 (pl)
AT (1) ATE398462T1 (pl)
AU (1) AU2005224179B2 (pl)
BR (1) BRPI0508941A (pl)
CA (1) CA2560532A1 (pl)
DE (1) DE602005007584D1 (pl)
DK (1) DK1727562T3 (pl)
ES (1) ES2306101T3 (pl)
NO (1) NO20063603L (pl)
NZ (1) NZ549592A (pl)
PL (1) PL1727562T3 (pl)
PT (1) PT1727562E (pl)
RU (1) RU2335298C2 (pl)
SI (1) SI1727562T1 (pl)
TW (1) TWI306404B (pl)
UA (1) UA86405C2 (pl)
WO (1) WO2005089793A1 (pl)
ZA (1) ZA200607132B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
CN103338785B (zh) * 2010-09-21 2015-01-14 英特维特国际股份有限公司 Bvdv疫苗
AR084358A1 (es) 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
PL2658570T3 (pl) * 2010-12-27 2019-05-31 Elanco Inc Sposoby i kompozycje szczepionki przeciwko wirusowi wirusowej biegunki bydła typu 1b
US9480739B2 (en) * 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593873A (en) * 1986-01-27 1997-01-14 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
US5709865A (en) * 1994-11-10 1998-01-20 Biostar Inc. Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6174667B1 (en) * 1997-09-23 2001-01-16 Cornell Research Foundation, Inc. Bovine viral diarrhea virus serum antigen capture
US6606457B2 (en) * 2001-06-19 2003-08-12 Pentax Corporation Focused image tremble correcting device
AU2002356520A1 (en) * 2001-08-09 2003-03-18 Cornell Research Foundation, Inc. Detection of bovine viral diarrhea virus in tissue samples

Also Published As

Publication number Publication date
DK1727562T3 (da) 2008-09-15
CA2560532A1 (en) 2005-09-29
JP4105220B2 (ja) 2008-06-25
EP1727562A1 (en) 2006-12-06
ATE398462T1 (de) 2008-07-15
TW200531701A (en) 2005-10-01
SI1727562T1 (sl) 2008-10-31
AU2005224179B2 (en) 2007-08-23
CN1929859A (zh) 2007-03-14
TWI306404B (en) 2009-02-21
EP1727562B1 (en) 2008-06-18
JP2007529498A (ja) 2007-10-25
RU2335298C2 (ru) 2008-10-10
BRPI0508941A (pt) 2007-08-14
RU2006133328A (ru) 2008-03-27
ZA200607132B (en) 2008-08-27
NO20063603L (no) 2006-09-08
AU2005224179A1 (en) 2005-09-29
NZ549592A (en) 2008-12-24
WO2005089793A1 (en) 2005-09-29
PT1727562E (pt) 2008-09-05
US20080260778A1 (en) 2008-10-23
ES2306101T3 (es) 2008-11-01
UA86405C2 (ru) 2009-04-27
AR048671A1 (es) 2006-05-17
DE602005007584D1 (de) 2008-07-31
KR20080036160A (ko) 2008-04-24
KR20060127199A (ko) 2006-12-11

Similar Documents

Publication Publication Date Title
TWI347184B (en) Methods of treating hiv infection
GB0325192D0 (en) Method of use
EP1656096A4 (en) METHODS OF REDUCING THE RISK OF INFECTION BY PATHOGENIC AGENTS
EP1656022A4 (en) METHOD FOR REDUCING THE RISK OF PATHOGENIC INFECTIONS
EP1855729A4 (en) sterilization
ZA200607115B (en) Permanent treatment method
EP1656088A4 (en) METHODS FOR REDUCING THE RISK OF INFECTION DUE TO PATHOGENS
IL182993A0 (en) Treatment of mastitis
ZA200607132B (en) Method of vaccination against testicular BVDV infection
EP1784221A4 (en) METHOD FOR THE TREATMENT AND PREVENTION OF INFECTIONS WITH ANTI-SELECTIN AGENTS
EP1827475A4 (en) METHOD FOR TREATING HIV INFECTION
EP1964538A4 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUBSTANCES
GB0422439D0 (en) Inhibitors of infection
GB0306309D0 (en) Method of treatment
GB0302572D0 (en) Method of treatment
GB0426196D0 (en) Methods of treatment
MY144154A (en) Method of combating infection
PL1721965T3 (pl) Sposób wytwarzania i zastosowanie kultur pierwotniaków
GB0501129D0 (en) Method of treatment by administration of RNA
GB0327975D0 (en) Methods of treatment
GB0415160D0 (en) Inhibitors of bacterial infection
GB0400633D0 (en) Method of vaccine preparation
GB0500932D0 (en) Method of vaccine preparation
GB0402389D0 (en) Method of cryopreservation
GB0300455D0 (en) Meyhod of vaccine preparation